Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Soochow UniversityNo recent work listed

Songbing He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2616-5802; OpenAlex author ID A5101676774. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.814312↗
  2. Effects of miR-16 plus CA19-9 detections on pancreatic cancer diagnostic performance. First author DOI 10.7754/clin.lab.2013.121210↗
  3. Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells. Co-author DOI 10.3892/or.2013.2478↗
  4. Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients. Co-author DOI 10.3390/ijms12117424↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dechun Li · 3 shared papers, 2011–2022 · strength 0.21
  2. Xin Zhao · 1 shared paper, 2022 · strength 0.11
  3. Jianhua Yu · 1 shared paper, 2022 · strength 0.11
  4. Kun‐Yu Teng · 1 shared paper, 2022 · strength 0.11
  5. Zheng Gang Zhu · 1 shared paper, 2022 · strength 0.11
  6. Yunyun Xu · 1 shared paper, 2022 · strength 0.11
  7. Zhenyu Dai · 1 shared paper, 2022 · strength 0.11
  8. Vincent M. Chung · 1 shared paper, 2022 · strength 0.11
  9. Jian Zhou · 1 shared paper, 2022 · strength 0.11
  10. Ling Gao · 1 shared paper, 2014 · strength 0.07
  11. Xinguo Zhu · 1 shared paper, 2013 · strength 0.04
  12. Peng-Fei Liu · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.